Openlane
OPLN · NYSE
About OPLN
- Employees
- 4,800
- Headquarters
- Carmel, Indiana
- Listed
- Dec 11, 2009
- Sector
- Industrials
- Industry
- Commercial Services & Supplies
- Website
- openlane.com
OPLN key statistics
- Market cap
- 4.63B
- Price-earnings ratio
- 0.00
- Dividend yield
- 0.48%
- Average volume
- 1.21M
- Volume
- 684.30K
- Open price
- $37.02
- High today
- $37.81
- Low today
- $36.80
- 52 Week high
- $42.90
- 52 Week low
- $24.32
Openlane (OPLN) at a glance
Openlane (OPLN) last traded at $37.71, with a market cap of 4.63B, a price-to-earnings ratio of 0.00 and a dividend yield of 0.48%.
Today the stock has traded between $36.80 and $37.81. The current price is 2.5% above the day's low and 0.3% below its high.
Volume so far is 684.30K shares, below the average of 1.21M shares a day.
Over the past year Openlane has ranged from $24.32 to $42.90, and now sits 72% of the way up that range.
Openlane met or beat analyst EPS estimates in 6 of the last 8 quarters. In Q2 FY26 it reported $0.40 per share against an estimate of $0.3609.
The average analyst price target is $47.30, 25.4% above the current price, from 5 recent ratings.
Analyst ratings
Latest rating from each analyst over the past 12 months
- Buy60.0%
- Hold40.0%
- Sell0.0%
- Low
- $43.43
- Now
- $37.71
- High
- $54.60
OPLN earnings
Earnings per share, reported against the analyst estimate
Beat the estimate in 6 of the last 8 quarters, by 25.6% on average.
- Q3 FY24: reported $0.26 per share against an estimate of $0.2229
- Q4 FY24: reported $0.21 per share against an estimate of $0.2108
- Q1 FY25: reported $0.31 per share against an estimate of $0.2184
- Q2 FY25: reported $0.33 per share against an estimate of $0.2244
- Q3 FY25: reported $0.35 per share against an estimate of $0.2805
- Q4 FY25: reported $0.25 per share against an estimate of $0.2662
- Q1 FY26: reported $0.35 per share against an estimate of $0.3113
- Q2 FY26: reported $0.40 per share against an estimate of $0.3609
OPLN news
- Press releasePRNewswire
- Press releasePRNewswire
OPENLANE Announces Pricing of Secondary Offering of Common Stock, Including Concurrent Share Repurchase
- Press releasePRNewswire
OPENLANE Announces Secondary Offering of Common Stock, Including Concurrent Share Repurchase
Full Transcript: Openlane Q2 2026 Earnings Call
- Press releasePRNewswire
OPENLANE, Inc. Reports Second Quarter 2026 Financial Results
- Press releasePRNewswire
OPENLANE to Announce Second Quarter 2026 Earnings
- Press releasePRNewswire
OPENLANE Announces Participation in Upcoming Investor Conference
- Press releasePRNewswire
OPENLANE Appoints Kelly Tuminelli and David Hult to Board of Directors
Similar companies
Companies in the same industry as Openlane
Most active stocks
Highest trading volume today
- EARIEntertainment Arts Research$0.0003−16.67%
- SEIISharing Economy International$0.0004+100.00%
- NWGLCL Workshop Group$0.1522+27.90%
- TMSHTrans Global Assets$0.0002+0.00%
- AEFIAmerican EcoFuels$0.0007+0.00%
- CBDW1606$0.0002+0.00%
- FITYFifty 1 Labs$0.0001−66.67%
- PRSOPeraso$0.5914+54.13%
- SDSTStardust Power$0.02−23.66%
- SHFSSHF Holdings$0.0899−4.36%
- FRTTFort Technology$0.7121+32.63%
- CBDLCBD Life Sciences$0.0002−25.00%
Newly listed
Companies that went public in the past six weeks
- TCXBTCGX Acquisition Corp. II$10.56+1.54%
- CTYCITY THERAPEUTICS$20.83−2.94%
- IAMIambic Therapeutics$16.01−2.02%
- AMROAmaero$5.68+1.25%
- FLSCFrazier Life Sciences Acquisition Corp. II$10.28−0.10%
- TRXBTRex Bio$14.44−2.43%
- RTSNRetension Pharmaceuticals$16.18−0.92%
- PAXGUPine Tree Acquisition$9.98+0.00%
- PORTUSouthport Acquisition Corp. IIListed Oct 1, 2026
- CHWMChilwa Minerals$5.18+3.39%
- ACCVAccelevation Holdings$12.31−1.44%
- RZAIROZE AI$10.28+1.28%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.